EPIDEMIOLOGICAL ASPECTS AND RISK FACTORS OF ISCHEMIC STROKE DEVELOPMENT (REVIEW OF THE LITERATURE)
https://doi.org/10.52485/19986173_2022_2_41
Abstract
Cerebrovascular diseases (CVD) are the main cause of disability and mortality in the adult population in the Russian Federation, the USA and European countries. The most severe form of CVD is acute cerebrovascular accident (ACVA). Despite significant progress in organizing medical care for patients who have suffered from an acute vascular accident, the mortality rate from this pathology in the Russian Federation remains one of the highest ones in the world. Ischemic stroke is a multifactorial disease based on risk factors, their correction significantly reduces the frequency of cerebral ischemia. The literature review presents modern epidemiological data on cerebrovascular pathology, highlights the pathogenetic classification of ischemic stroke, and considers the main risk factors for its occurrence.
About the Authors
A. Yu. Ma-Van-deRussian Federation
39a Gorky Street, Chita, 672000
Yu. A. Vitkovsky
Russian Federation
39a Gorky Street, Chita, 672000
Yu. A. Shirshov
Russian Federation
39a Gorky Street, Chita, 672000
References
1. Neurology. National leadership. - acad. RAS E.I. Gusev, acad. RAS A.N. Konovalov, prof. A.B. Hecht. Moscow "GEOTAR-Media", 2019. in Russian.
2. Groppa S. In the Republic of Moldova there is an epidemic of cerebral vascular diseases. Moldova, 2019.
3. Groppa S., Zota E., Crivorucica I. Accidentul vascular cerebral ischemic: Protocol clinic instituțional. Chisinau; 2018. Romanian.
4. Mishin I.A. Dyslipidemia and arterial hypertension as a risk factor for ischemic and hemorrhagic stroke in young patients. Bulletin of new medical technologies. 2017. 11(4). 130-135. in Russian.
5. Piradov M.A. Maksimova M.Yu., Tanashyan M.M. Stroke: step by step instructions. Guide for doctors. 2nd ed., revised. and additional Moscow: GEOTAR-Media. 2020. ISBN 978-5-9704-5782-5. in Russian.
6. Oleinikova T.A., Titova A.A., Evstratov A.V. Current state and trends in the incidence of cerebral infarction in Russia. Modern problems of public health and medical statistics. 2021. 2. 522-535. in Russian.
7. Machinsky P. A., Plotnikova N. A., Ulyankin V. E., Kemaykin S. P., Rybakov A. G. Comparative characteristics of mortality and mortality from ischemic and hemorrhagic strokes in Russia. Izvestiya vuzov. Volga region. Medical Sciences. 2019. 3 (51). 101-118. in Russian.
8. Aarnio K., Haapaniemi E., Melkas S. Long-term mortality after first-ever and recurrent stroke in young adults. Stroke. 2014. 45(9). 2670-2676.
9. Mashin V.V. Modern approaches to the rehabilitation of patients with movement disorders. Remedium Privolzhye. 2018. 3 (163). 29-33. in Russian.
10. Pinto A., Tuttolomondo A., Raimondo D. Di. Risk factors profile and clinical outcome of ischemic stroke patients admitted in a Department of Internal Medicine and classified by TOAST classification. International Angiology. 2006. 25. 261-267.
11. Spacek M., Zemanek D., Hutyra M. Vulnerable atherosclerotic plaque – a review of current concepts and advanced imaging. Biomedical Papers. 2018. 162(1). 10-17. doi:10.5507/bp.2018.004.
12. Merkulova G.P. Transient ischemic attacks. MNS. 2012. 2 (41). 13-17. in Russian.
13. Wang D., Liu M., Hao Z., Tao W. Association between reduced kidney function and clinical outcomes after ischaemic stroke with atrial fibrillation. European Journal of Neurology. 2014. 21(1). 160–6.
14. Maksimova M.Yu., Gulevskaya T.S. Lacunar stroke. Journal of Neurology and Psychiatry. S.S. Korsakov. 2019. 119(8). 3-27. in Russian.
15. Goldobin V.V., Klocheva E.G., Sirotkina O.V. Clinical and hemorheological disorders in patients with lacunar strokes. Bulletin of the Russian Military Medical Academy. 2012. 1(37). 145-149. in Russian.
16. Egeto P., Fischer C., Ismail Z. Lacunar stroke, deep white matter disease and depression: a metaanalysis. International Psychogeriatrics. 2014. 26(7). 1101-1109.
17. Kalashnikova L. A., Dobrynina L. A. Dissection of cerebral arteries: ischemic stroke and other clinical manifestations. M.: Publishing house "Vako", 2013. in Russian.
18. Ekker M. S., Boot E. M., Singhal A. B. Epidemiology, aetiology, and management of ischaemic stroke in young adults. Lancet Neurol. 2018. 17. 790-801.
19. Khamashta M. Antiphospholipid syndrome. Best Practice & Research: Clinical Rheumatology. 2016. 30(1). 133-148.
20. Goncharova A.A., Kravchenko E.N., Krivchik G.V., Votrina I.R., Chebakova V.Yu. Antiphospholipid syndrome in obstetric practice. MID. 2018. 1. 52-56. in Russian.
21. Kurth T., Chabriat H., Bousser M.G. Migraine and stroke: a complex association with clinical implications. Lancet Neurol. 2012. 11. 92-100.
22. Kulesh A.A., Drobakha V.E., Shestakov V.V. Cerebral sporadic non-amyloid microangiopathy: pathogenesis, diagnosis and treatment tactics. Neurology, neuropsychiatry, psychosomatics. 2018. 10(4). 13-22. in Russian.
23. Guidelines for the Early Management of Patients with Acute Ischemic Stroke. A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association. Stroke 2018. 49(3). 46-110.
24. Maksimova M.Yu., Moskvicheva A.S., Chechetkin A.O. Changes in androgen status in men with atherothrombotic stroke. Annals of clinical and experimental neurology. 2017. 3. 29.34. in Russian.
25. Al Salmi I., Hannawi S. Birth weight is inversely correlated with blood pressure: population- based study. Journal of Hypertension. 2020. 38 (11). 2205-2214.
26. Ediriweera D.S., Dilina N., Perera U. Risk of low birth weight on adulthood hypertension — evidence from a tertiary care hospital in a South Asian country, Sri Lanka: a retrospective cohort study. BMC Public Health. 2017. 17 (1). 358.
27. Gardener H., Sacco R.L., Rundek T., Battistella V., Cheung YK., Elkind M.S.V. Race and Ethnic Disparities in Stroke Incidence in the Northern Manhattan Study. Stroke. 2020. 51(4). 1064-1069. doi: 10.1161/STROKEAHA.119.028806.
28. Cipolla M.J., Liebeskind D.S., Chan S.L. The importance of comorbidities in ischemic stroke: Impact of hypertension on the cerebral circulation. Journal of Cerebral Blood Flow & Metabolism. 2018. 38(12). 2129-2149.
29. Wright J.T. Jr., Williamson J.D., Whelton P.K., Snyder J.K., Sink K.M., Rocco M.V., Reboussin D.M., Rahman M., Oparil S., Lewis C.E., Kimmel P.L., Johnson K.C., Goff D.C. Jr., Fine L.J., Cutler J.A., Cushman W.C., Cheung A.K., Ambrosius W.T. A Randomized Trial of Intensive versus Standard Blood-Pressure Control. The New England Journal of Medicine 2015. 26. 373 (22). 2103-2116.
30. Barkhatov Yu.D., Kadykov A.S. Factors affecting the recovery of motor functions in patients with hemispheric cerebral infarction of various localization. Nervous diseases. 2018. 4. 41-49. in Russian.
31. Chulkov V. S., Gavrilova E. S., Chulkov Vl. S., Pankova E. D., Lenets E. A., Tkachenko P. E. Primary prevention of cardiovascular diseases: focus on the correction of behavioral risk factors. Russian journal of cardiology. 2021. S3. 67-72. in Russian.
32. German C.A, Shapiro M.D. Atherosclerotic cardiovascular disease risk with advanced lipid testing: state of the science. European Cardiology Review 2020. Jul 15. e56.
33. Antonova K.V., Medvedev R.B., Shabalina A.A., Lagoda O.V., Tanashyan M.M. Disorders of carbohydrate metabolism and cerebral atherosclerosis in patients with ischemic disorders of cerebral circulation. Annals of Clinical and Experimental Neurology 2016. 10(1). 20-6. in Russian.
34. Singh P., Zhang Y., Sharma P., Covassin N., Soucek F., Friedman P.A., Somers V.K. Statins decrease leptin expression in human white adipocytes. Physiological Reports 2018. 6(2). e13566.
35. Lu Y. Metabolic mediators of the effects of body-mass index, overweight, and obesity on coronary heart disease and stroke: A pooled analysis of 97 prospective cohorts with 1.8 million participants. The Lancet. 2014. 383. 970-983.
36. Roach R.E., Helmerhorst F.M., Lijfering W.M. Combined oral contraceptives: the risk of myocardial infarction and ischemic stroke. Cochrane Database Syst Rev. 2015. 27(8). 1-55.
37. Lima A.C.S., Martins L.C.G, Lopes M.V.O. Influence of hormonal contraceptives and the occurrence of stroke: integrative review. Rev Bras Enferm [Internet]. 2017. 70(3). 647–655. DOI: 10.1590/0034-7167-2016-0056.
38. Xu Zh., Li Y., Tang Sh. et al. Current use of oral contraceptives and the risk of first-ever ischemic stroke: A meta-analysis of observational studies. Thrombosis Research. 2015. 1(136). 52–60. DOI: 10.1016/j.thromres.2015.04.021.
39. Young T., Finn L., Peppard P.E., Szklo-Coxe M., Austin D., Nieto F.J. Sleep disordered breathing and mortality: eighteen-year follow-up of the Wisconsin sleep cohort. Sleep. 2008. 31(8). 1071-1078.
40. Arboix A. Cardiovascular risk factors for acute stroke: Risk profiles in the different subtypes of ischemic stroke. World J Clin Cases. 2015. 3. 418-429.
41. Kumar M., Mahajan A., Sapehia D. Effects of altered maternal folate and vitamin B12 on neurobehavioral outcomes in F1 male mice. Brain Research Bulletin. 2019. 153. 93-101. doi: 10.1016/j.brainresbull.2019.07.031.
42. Moretti R., Caruso P. The Controversial Role of Homocysteine in Neurology: From Labs to Clinical Practice. Int J Mol Sci. 2019. 20(1). 231. doi:10.3390/ijms20010231.
43. Zhang T., Jiang Y., Zhang S., Tie T., Cheng Y., Su X., Man Z., Hou J., Sun L., Tian M., Zhang Y., Li J., Ma Y. The association between homocysteine and ischemic stroke subtypes in Chinese: A meta-analysis. Medicine (Baltimore). 2020 March. 99(12): e19467
44. Forti P., Maioli F., Arnone G., Coveri M., Pirazzoli G.L., Zoli1 M., Procaccianti G. Homocysteinemia and early outcome of acute ischemic stroke in elderly patients. Brain Behav. 2016. 6. e00460. doi: 10.1002/brb3.460.
45. Shi Z., Guan Y., Hou Y.R. Elevated total homocysteine levels in acute ischemic stroke are associated with long-term mortality. Stroke. 2015. 46. 2419-2425.
46. Sharif Nia H., Chan Y. H., Froelicher E. S., Pahlevan Sharif S., Yaghoobzadeh A., Jafari A. Weather fluctuations: predictive factors in the prevalence of acute coronary syndrome. Health Promot. Perspect. 2019. 9 (2). 123-130. DOI: 10.15171/hpp.2019.17.
47. Chu S.Y., Cox M., Fonarow G.C., Smith E.E., Schwamm L., Bhatt D.L., Matsouaka R.A., Xian Y., Sheth K.N. Temperature and Precipitation Associate with Ischemic Stroke Outcomes in the United States. J Am Heart Assoc. 2018. 20. 7(22). 1-11.
48. Chen X., Shang W., Huang X., Shu L., Xiao S., Jiang Q., Hong H. The Effect of Winter Temperature on Patients with Ischemic Stroke. Medical Science Monitor. 2019. May 23. 3839-3845.
49. Oganov R.G., Simanenkov V.I., Bakulin I.G. Comorbid pathology in clinical practice. Algorithms for diagnosis and treatment. Cardiovascular therapy and prevention. 2019. 18(1). 5-66. in Russian.
50. Nambiar V.K., Chalappurath D.R. Thrombotic tendencies in excess catecholamine states. Biogenic Amines in Neurotransmission and Human Disease. London, United Kingdom, 2019.
Review
For citations:
Ma-Van-de A.Yu., Vitkovsky Yu.A., Shirshov Yu.A. EPIDEMIOLOGICAL ASPECTS AND RISK FACTORS OF ISCHEMIC STROKE DEVELOPMENT (REVIEW OF THE LITERATURE). Transbaikalian Medical Bulletin. 2022;(2):41-52. (In Russ.) https://doi.org/10.52485/19986173_2022_2_41